Pablo Granados
Valencia, VC, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
A comparative performance evaluation of the VIDAS cytomegalovirus (CMV) interferon-gamma release assay (IGRA) and T-SPOT CMV for measuring CMV-specific T-cell responses in allogeneic hematopoietic stem cell transplant recipients receiving letermovir prophylaxis.
Journal: Journal of clinical microbiology
Published: July 27, 2026
Secondary Malignancies after Hematopoietic Stem Cell Transplantation.
Journal: Transplantation and cellular therapy
Published: March 16, 2026
Secondary Malignancies After Hematopoietic Stem Cell Transplantation.
Journal: Transplantation and cellular therapy
Published: March 16, 2026
Maribavir for clinically significant cytomegalovirus infection in haematopoietic cell transplant recipients in Europe: a real-world multicentre retrospective registry study.
Journal: The Lancet. Infectious diseases
Published: January 12, 2026
Bone Marrow Transplantation From Matched and Mismatched Unrelated Donors With Post-Transplant Cyclophosphamide for Patients With Severe Aplastic Anemia.
Journal: Transplantation and cellular therapy
Published: November 12, 2025
Chronic graft-versus-host disease in the era of posttransplant cyclophosphamide.
Journal: Haematologica
Published: September 28, 2025
Bacterial Bloodstream Infections After Hematopoietic Cell Transplantation With Post-Transplant Cyclophosphamide.
Journal: Transplantation and cellular therapy
Published: August 08, 2025
Mold Invasive Fungal Infection in Hematopoietic Cell Transplant With Post-Transplant Cyclophosphamide and Posaconazole Prophylaxis.
Journal: Transplantation and cellular therapy
Published: May 26, 2025
Redefining Engraftment Syndrome After Post-Transplant Cyclophosphamide Allogeneic Hematopoietic Cell Transplantation: A Novel Classification and Impact on Outcomes.
Journal: Transplantation and cellular therapy
Published: April 08, 2025
Sinusoidal Obstruction Syndrome After Allogeneic Hematopoietic Cell Transplantation With Post-Transplant Cyclophosphamide.
Journal: Transplantation and cellular therapy
Published: April 07, 2025
Genetic risk classification in acute myeloid leukemia patients treated with hematopoietic cell transplantation and post-transplant cyclophosphamide.
Journal: Haematologica
Published: March 18, 2025
Infectious Enterocolitis in Hematopoietic Cell Transplant with Post-Transplant Cyclophosphamide.
Journal: Transplantation and cellular therapy
Published: December 31, 2024
Last Updated: 09/26/2026